Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Forsyth

Showing results (371-380 of 406) with videos related to

Pageof 41
Sort By:
The Journal of Biological Chemistry|February 13, 2014
p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cellsPeter A Forsyth, Niveditha Krishna, Samuel Lawn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of gliomaXueQing Lun, Jennifer Chan, Hongyuan Zhou, et al.
Neuro-Oncology|September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular AnalysesYolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Cancer Research|March 11, 2010
Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeuticChandini M Thirukkumaran, Michael J Nodwell, Kensuke Hirasawa, et al.
Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
Nature Communications|July 19, 2018
Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Pageof 41

Showing results (371-380 of 406) with videos related to

Sort By:
Pageof 41
The Journal of Biological Chemistry|February 13, 2014
p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cellsPeter A Forsyth, Niveditha Krishna, Samuel Lawn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2010
Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of gliomaXueQing Lun, Jennifer Chan, Hongyuan Zhou, et al.
Neuro-Oncology|September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular AnalysesYolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Cancer Research|March 11, 2010
Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeuticChandini M Thirukkumaran, Michael J Nodwell, Kensuke Hirasawa, et al.
Nature Communications|February 16, 2017
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
Nature Communications|July 19, 2018
Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastomaShawn T Beug, Caroline E Beauregard, Cristin Healy, et al.
BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Pageof 41